Tradjenta and Brovana drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Tradjenta (linagliptin) and Brovana (arformoterol tartrate). Common drug interactions include diarrhoea among females and asthma among males.

The phase IV clinical study analyzes what interactions people have when they take Tradjenta and Brovana. It is created by eHealthMe based on reports of 18 people who take the same drugs from the FDA, and is updated regularly.

What is Tradjenta?

Tradjenta has active ingredients of linagliptin. It is often used in diabetes. eHealthMe is studying from 9,987 Tradjenta users. Check the latest studies of Tradjenta.

What is Brovana?

Brovana has active ingredients of arformoterol tartrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 3,656 Brovana users. Check the latest studies of Brovana.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

18 people who take Tradjenta and Brovana together, and have interactions are studied.

Tradjenta and Brovana drug interactions.

What are the common drug interactions of Tradjenta and Brovana, by gender? *:

female:

Diarrhoea
Drug ineffective
Arthritis (form of joint disorder that involves inflammation of one or more joints)
Hospitalisation
Hypertension (high blood pressure)
Oral candidiasis (fungal infection of mouth)
Vomiting
Hypotonia (low muscle tone)
Mobility decreased (ability to move is reduced)
Cataplexy (loss of muscle tone accompanied by full conscious awareness)

male:

Asthma
Blood glucose increased
Glycosylated haemoglobin increased
Haemophilus infection (bacterial infection by haemophilus influenzae)
Head injury
Hypervolaemia (abnormally increased volume of blood)
Hypovolaemia (a decreased volume of circulating blood in the body)
Leukocytosis (increased white blood cells)
Lipids increased (excess lipid in body)
Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Tradjenta and Brovana, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Asthma
Blood glucose increased
Hypovolaemia (a decreased volume of circulating blood in the body)
Leukocytosis (increased white blood cells)
Lipids increased (excess lipid in body)
Nausea (feeling of having an urge to vomit)
Osteopenia (a condition where bone mineral density is lower than normal)
Pain
Pulmonary mass
Skin injury

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 14 people, 77.78%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 13 people, 72.22%
Immunodeficiency Common Variable: 2 people, 11.11%
Drowsiness: 2 people, 11.11%
Stress And Anxiety: 1 person, 5.56%
Neuralgia (pain in one or more nerves): 1 person, 5.56%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Tradjenta and Brovana?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously